Kalvista Pharmaceuticals logo

Kalvista Pharmaceuticals Share Price (NASDAQ: KALV)

$13.48

-0.03

(-0.22%)

Last updated on

Check the interactive Kalvista Pharmaceuticals Stock chart to analyse performance

Kalvista Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$13.23
    Today's High:$13.74

    Day's Volatility :3.71%

  • 52 Weeks Low:$7.30
    52 Weeks High:$16.32

    52 Weeks Volatility :55.27%

Kalvista Pharmaceuticals Stock Returns

PeriodKalvista Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
4.26%
3.6%
0.0%
6 Months
23.92%
-7.7%
0.0%
1 Year
8.89%
-12.6%
0.0%
3 Years
-19.96%
10.2%
-4.1%

Kalvista Pharmaceuticals Inc Key Stats

Check Kalvista Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$13.51
Open
$13.695
Today's High
$13.74
Today's Low
$13.23
Market Capitalization
$680.1M
Today's Volume
$436.5K
52 Week High
$16.32
52 Week Low
$7.3
Revenue TTM
$3.8M
EBITDA
$-187.1M
Earnings Per Share (EPS)
$-3.69
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-121.5%

Stock Returns calculator for Kalvista Pharmaceuticals Stock including INR - Dollar returns

The Kalvista Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kalvista Pharmaceuticals investment value today

Current value as on today

₹1,14,257

Returns

₹14,257

(+14.26%)

Returns from Kalvista Pharmaceuticals Stock

₹8,973 (+8.97%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Kalvista Pharmaceuticals Stock

-90%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Kalvista Pharmaceuticals Stock from India on INDmoney has decreased by -90% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Kalvista Pharmaceuticals Inc

  • Name

    Holdings %

  • VR Adviser, LLC

    13.47%

  • Suvretta Capital Management, LLC

    9.92%

  • TANG CAPITAL MANAGEMENT LLC

    9.89%

  • Vestal Point Capital LP

    9.51%

  • Capital World Investors

    6.36%

  • BlackRock Inc

    6.31%

Analyst Recommendation on Kalvista Pharmaceuticals Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Kalvista Pharmaceuticals(by analysts ranked 0 to 5 stars)

Kalvista Pharmaceuticals Share Price Target

What analysts predicted

Upside of 134.92%

Target:

$31.67

Current:

$13.48

Kalvista Pharmaceuticals share price target is $31.67, a slight Upside of 134.92% compared to current price of $13.48 as per analysts' prediction.

Kalvista Pharmaceuticals Stock Insights

  • Price Movement

    In the last 6 months, KALV stock has moved up by 18.2%
  • KALV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 69.3%
  • KALV vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 134.2%
  • Price to Sales

    ForKALV every $1 of sales, investors are willing to pay $62.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Kalvista Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Kalvista Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Kalvista Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kalvista Pharmaceuticals Inc logo
1.97%
23.92%
8.89%
-19.96%
6.57%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Kalvista Pharmaceuticals Inc

KalVista Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is EKTERLY, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. KalVista Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Organization
Kalvista Pharmaceuticals
Employees
270
CEO
Mr. Benjamin L. Palleiko
Industry
Health Technology

Key Management of Kalvista Pharmaceuticals Inc

NameTitle
Mr. Benjamin L. Palleiko
CEO & Director
Mr. Brian Piekos
Chief Financial Officer
Dr. Paul K. Audhya M.B.A., M.D.
Chief Medical Officer
Mr. Ryan Baker
Head of Investor Relations
Mr. Brian Krex J.D.
General Counsel
Jarrod Aldom
Vice President of Corporate Communications
Ms. Rachel M. Morten
Senior Vice President of Regulatory Affairs & QA
Dr. Christopher M. Yea Ph.D.
Chief Development Officer
Dr. Michael D. Smith Pharm.D.
Senior Vice President of Development
Ms. Nicole Sweeny
Chief Commercial Officer

Important FAQs about investing in KALV Stock from India :

What is Kalvista Pharmaceuticals share price today?

Kalvista Pharmaceuticals share price today is $13.48 as on at the close of the market. Kalvista Pharmaceuticals share today touched a day high of $13.74 and a low of $13.23.

What is the 52 week high and 52 week low for Kalvista Pharmaceuticals share?

Kalvista Pharmaceuticals share touched a 52 week high of $16.32 and a 52 week low of $7.30. Kalvista Pharmaceuticals stock price today i.e. is closed at $13.48, lower by 17.4% versus the 52 week high.

How to invest in Kalvista Pharmaceuticals Stock (KALV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kalvista Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalvista Pharmaceuticals Shares that will get you 0.1113 shares as per Kalvista Pharmaceuticals share price of $13.48 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Kalvista Pharmaceuticals Stock (KALV) from India?

Indian investors can start investing in Kalvista Pharmaceuticals (KALV) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Kalvista Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Kalvista Pharmaceuticals share’s latest price of $13.48 as on August 30, 2025 at 1:29 am IST, you will get 0.7418 shares of Kalvista Pharmaceuticals. Learn more about fractional shares .

What are the returns that Kalvista Pharmaceuticals has given to Indian investors in the last 5 years?

Kalvista Pharmaceuticals stock has given 6.57% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?